Chemotherapy and your vagina, ovaries, uterus and cervix

Chemotherapy drugs are delivered in several ways, and treatment can have a variety of implications on the vagina and surrounding tissues.

Each cancer is in a different spot, is a different size, and may be treated in its own right by your physicians. This means the fallout of chemotherapy will be unique to each woman.​1​

What can happen during chemo in the pelvic area

Bladder cancer chemotherapy treatments and your vagina/urethra

Sometimes the drugs are put directly into the bladder by catheter, inserted via the urethra. This type of administration has a very minor impact on that area, but trying to have sex too soon after treatment could cause discomfort.

Pelvic tumour chemotherapy treatments and your vagina

Pelvic tumours may be treated by pelvic infusion of chemo drugs via the major arteries that feed the pelvis (via the bloodstream).

The long-term impact of this delivery method on your pelvic area isn’t really known yet. Short-term impacts are much like traditional IV methods.

Ovarian or colon cancer chemotherapy treatments and your vagina

Sometimes chemo will be given via intraperitoneal infusion, which means the drugs are put right into the abdomen.

The space around the intestines and ovaries is filled up with chemotherapy drug, causing some abdominal swelling, after which the liquid is drained away. This treatment can be quite uncomfortable, but this will dissipate.​2​

Pregnancy and fertility outcomes of chemotherapy treatment

If you want to become pregnant later on, you should discuss this before you start treatment, because many chemotherapy drugs damage the ovaries, reducing oestrogen output.​3​

You may wish to get eggs removed and frozen, for later use.​4,5​ You will be advised to use some form of birth control to avoid getting pregnant during treatment, because most chemo drugs are toxic and will harm a foetus.

Speak to your doctor about how long you should wait after treatment to try getting pregnant.

Menopause (whether you like it or not) after chemotherapy due to ovarian failure

Sometimes chemotherapy can trigger early menopause, with associated symptoms, due to ovarian failure – that is, your ovaries stop working completely.​6​

Menopausal symptoms can include disruptions to vaginal moisture and natural lubrication, vaginal tissue deterioration, issues with vaginal tone, hot flashes, and interruptions or an end to your periods.

You may bleed after sex or get spotting between periods.

Chemotherapy irritations to mucous membranes

Mucous membranes – like those in the vagina – are affected by some chemotherapy drugs. Your vagina can become dry and irritated, with more yeast infections.​7​

If you’re taking steroids or antibiotics, your yeast infection rate is likely to go up, with associated symptoms of burning, itching, discharge, and rawness.

Herpes or HPV virus flare-ups

Chemo can trigger a latent genital herpes or genital warts (HPV) flare-up, but only if you’ve had them previously.

Your immunity is severely interrupted by chemotherapy, so see your doctor for help with a break-out.

Your libido on chemo

Women receiving chemotherapy are very likely to see a decrease in their sexual desire.​8​

Chemo is draining for lots of reasons, and these uncomfortable symptoms or side-effects can really put a damper on your sex life due to a simple lack of energy.

Your sexual desire is likely to return when you feel better, which might occur right near the next chemo session if your sessions are weeks apart.

Another obvious side-effect that puts a damper on things is hair loss, but there are other elements that aren’t always predictable that can interfere with body image and confidence, like weight gain and the omnipresent tubes that may stay in your flesh for weeks or months.​9,10​

Talk to your healthcare practitioner and find support

There are so many support services, including social media groups, for those undergoing and recovering from cancer treatments. You are not alone!

References

  1. 1.
    Haryani, Hsu YY, Wang ST. Symptom clusters change over time among patients with gynecological cancer receiving chemotherapy. European Journal of Oncology Nursing. Published online October 2022:102193. doi:10.1016/j.ejon.2022.102193
  2. 2.
    Jaaback K, Johnson N, Lawrie TA. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. Cochrane Database of Systematic Reviews. Published online January 12, 2016. doi:10.1002/14651858.cd005340.pub4
  3. 3.
    Poorvu PD, Frazier AL, Feraco AM, et al. Cancer Treatment-Related Infertility: A Critical Review of the Evidence. JNCI Cancer Spectrum. Published online March 1, 2019. doi:10.1093/jncics/pkz008
  4. 4.
    Kim JH, Alzahrani HS, Lee SR, Kim SH, Chae HD. Outcomes of Fertility Preservation for Female Cancer Patients in a Single Tertiary Center. Yonsei Med J. Published online 2023:497. doi:10.3349/ymj.2023.0009
  5. 5.
    Oktay K, Rodriguez-Wallberg K. Fertility preservation during cancer treatment: clinical guidelines. CMAR. Published online March 2014:105. doi:10.2147/cmar.s32380
  6. 6.
    Martin HL, Ullah S, Abbas N, et al. Predicting chemotherapy‐induced menopause using baseline and post‐chemotherapy anti‐Müllerian hormone levels: Results of a pilot study. Cancer Reports. Published online March 3, 2021. doi:10.1002/cnr2.1342
  7. 7.
    KRYCHMAN M, CARTER J, AGHAJANIAN C, DIZON D, CASTIEL M. Chemotherapy-induced dyspareunia: a case study of vaginal mucositis and pegylated liposomal doxorubicin injection in advanced stage ovarian carcinoma. Gynecologic Oncology. Published online May 2004:561-563. doi:10.1016/j.ygyno.2004.02.001
  8. 8.
    Shankar A, Prasad N, Roy shubham, et al. Sexual Dysfunction in Females after Cancer Treatment: an Unresolved Issue. APJCP. Published online May 2017. doi:10.22034/APJCP.2017.18.5.1177
  9. 9.
    Nowosielski K, Pałka A. Couples’ sexual health after gynaecological cancer diagnosis – an unexplored area for further research. wo. Published online 2023:47-56. doi:10.5114/wo.2023.127308
  10. 10.
    Beesley VL, Ross TL, King MT, et al. Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns). Gynecologic Oncology. Published online February 2022:437-445. doi:10.1016/j.ygyno.2021.12.006


NEW!
(1) USD $34.95

Specially formulated probiotic for vaginal application to promote a healthy vaginal microbiome.

BEST FOR BV
(8) USD $39.95

Naturopath-developed 100% natural, effective BV treatment.

EXPERT
(8) Original price was: USD $9.95.Current price is: USD $0.00.

Unique, comprehensive BV, AV and 'mystery bad vag' treatment guide, one-of-a-kind system, with effective, innovative treatments.

SHARE YOUR CART